Human immunodeficiency virus
gp120
  1G9M	HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
  1G9N	HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
  1GC1	HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
  1HHG	THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
  1NIZ	NMR STRUCTURE OF A V3 (MN ISOLATE) PEPTIDE BOUND TO 447-52D, A HUMAN HIV-1 NEUTRALIZING ANTIBODY
  1NJ0	NMR STRUCTURE OF A V3 (MN ISOLATE) PEPTIDE BOUND TO 447-52D, A HUMAN HIV-1 NEUTRALIZING ANTIBODY
  1RZJ	HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
  1RZK	HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
  1YYL	CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
  1YYM	CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
  2B4C	CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
  2I5Y	CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
  2I60	CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
  2NXY	HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
  2NXZ	HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
  2NY0	HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
  2NY1	HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
  2NY2	HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
  2NY3	HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
  2NY4	HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
  2NY5	HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
  2NY6	HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
  2NY7	HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12
  3GWO	STRUCTURE OF THE C-TERMINAL DOMAIN OF A PUTATIVE HIV-1 GP41 FUSION INTERMEDIATE
  3H00	STRUCTURE OF THE C-TERMINAL DOMAIN OF A PUTATIVE HIV-1 GP41 FUSION INTERMEDIATE
  3H01	STRUCTURE OF THE C-TERMINAL DOMAIN OF A PUTATIVE HIV-1 GP41 FUSION INTERMEDIATE
  3HI1	STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
  3IDX	CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222
  3IDY	CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C2221
  3JWD	STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
  3MLR	CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
  3MLT	CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
  3MLU	CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE
  3MLV	CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
  3MLY	CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
  3MLZ	CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE
  3SE8	CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120
  3SE9	CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG04 IN COMPLEX WITH HIV-1 GP120
  3U2S	CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
gp41
  1CZQ	CRYSTAL STRUCTURE OF THE D10-P1/IQN17 COMPLEX: A D-PEPTIDE INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 COILED-COIL POCKET.
  1DF4	INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION
  1DF5	INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION
  1DLB	HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDES
  1F23	CONTRIBUTION OF A BURIED HYDROGEN BOND TO HIV-1 ENVELOPE GLYCOPROTEIN STRUCTURE AND FUNCTION
  1I5X	HIV-1 GP41 CORE
  1I5Y	HIV-1 GP41 CORE
  1K33	CRYSTAL STRUCTURE ANALYSIS OF THE GP41 CORE MUTANT
  1K34	CRYSTAL STRUCTURE ANALYSIS OF GP41 CORE MUTANT
  1QR8	INHIBITION OF HIV-1 INFECTIVITY BY THE GP41 CORE: ROLE OF A CONSERVED HYDROPHOBIC CAVITY IN MEMBRANE FUSION
  1QR9	INHIBITION OF HIV-1 INFECTIVITY BY THE GP41 CORE: ROLE OF A CONSERVED HYDROPHOBIC CAVITY IN MEMBRANE FUSION
  1SZT	ATOMIC STRUCTURE OF A THERMOSTABLE SUBDOMAIN OF HIV-1 GP41
  2CMR	CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX
  2OT5	CRYSTAL STRUCTURE OF THE HIV GP41 CORE WITH THE ENFUVIRTIDE RESISTANCE MUTATION N43D
  2X7R	CRYSTAL STRUCTURE OF A LATE FUSION INTERMEDIATE OF HIV-1 GP41
  3AHA	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN GP41 FRAGMENTS N36 AND C34 MUTANT N126K/E137Q
  3CP1	STRUCTURE OF A LONGER THERMALSTABLE CORE DOMAIN OF HIV-1 GP41 CONTAINING THE ENFUVIRTIDE RESISTANCE MUTATION N43D
  3CYO	STRUCTURE OF A LONGER THERMALSTABLE CORE DOMAIN OF HIV-1 GP41 CONTAINING THE ENFUVIRTIDE RESISTANCE MUTATION N43D AND COMPLEMENTARY MUTATION E137K
  3GWO	STRUCTURE OF THE C-TERMINAL DOMAIN OF A PUTATIVE HIV-1 GP41 FUSION INTERMEDIATE
  3H00	STRUCTURE OF THE C-TERMINAL DOMAIN OF A PUTATIVE HIV-1 GP41 FUSION INTERMEDIATE
  3H01	STRUCTURE OF THE C-TERMINAL DOMAIN OF A PUTATIVE HIV-1 GP41 FUSION INTERMEDIATE
  3K9A	CRYSTAL STRUCTURE OF HIV GP41 WITH MPER
  3MA9	CRYSTAL STRUCTURE OF GP41 DERIVED PROTEIN COMPLEXED WITH FAB 8066
  3P30	CRYSTAL STRUCTURE OF THE CLUSTER II FAB 1281 IN COMPLEX WITH HIV-1 GP41 ECTODOMAIN
matrix
  1HIW	TRIMERIC HIV-1 MATRIX PROTEIN
  2GOL	XRAY STRUCTURE OF GAG278
  2HMX	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 MATRIX PROTEIN
  2K4E	SOLUTION STRUCTURE OF THE HIV-2 UNMYRISTOYLATED MATRIX PROTEIN
  2K4H	SOLUTION STRUCTURE OF THE HIV-2 MYRISTOYLATED MATRIX PROTEIN
  2K4I	SOLUTION STRUCTURE OF HIV-2 MYRMA BOUND TO DI-C4-PI(4,5)P2
  3DOX	X-RAY STRUCTURE OF HIV-1 PROTEASE IN SITU PRODUCT COMPLEX
  3DPH	HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S)
  3IG1	HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
  3JVW	HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323
  3JVY	HIV-1 PROTEASE MUTANT G86A WITH DARUNAVIR
  3JW2	HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR
p24
  1AFV	HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
  1BMX	HIV-1 CAPSID PROTEIN MAJOR HOMOLOGY REGION PEPTIDE ANALOG, NMR, 8 STRUCTURES
  1E6J	CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
  2GOL	XRAY STRUCTURE OF GAG278
  2GON	XRAY STRUCTURE OF GAG133-278
  2JYG	SOLUTION STRUCTURE OF THE W184A/M185A MUTANT OF THE CARBOXY- TERMINAL DIMERIZATION DOMAIN OF THE HIV-1 CAPSID PROTEIN
  2JYL	SOLUTION STRUCTURE OF A DOUBLE MUTANT OF THE CARBOXY- TERMINAL DIMERIZATION DOMAIN OF THE HIV-1 CAPSID PROTEIN
  2L6E	NMR STRUCTURE OF THE MONOMERIC MUTANT C-TERMINAL DOMAIN OF HIV-1 CAPSID IN COMPLEX WITH STAPLED PEPTIDE INHIBITOR
  2ONT	A SWAPPED DIMER OF THE HIV-1 CAPSID C-TERMINAL DOMAIN
  2X2D	ACETYL-CYPA:HIV-1 N-TERM CAPSID DOMAIN COMPLEX
  2X82	EVOLUTIONARY BASIS OF HIV RESTRICTION BY THE ANTIRETROVIRAL TRIMCYP
  2XV6	CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN (146-220) IN COMPLEX WITH A CAMELID VHH.
  2XXM	CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN IN COMPLEX WITH A CAMELID VHH AND THE CAI PEPTIDE.
  3DIK	PSEUDO-ATOMIC MODEL OF THE HIV-1 CA HEXAMERIC LATTICE
  3DOX	X-RAY STRUCTURE OF HIV-1 PROTEASE IN SITU PRODUCT COMPLEX
  3DPH	HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S)
  3GV2	X-RAY STRUCTURE OF HEXAMERIC HIV-1 CA
  3H47	X-RAY STRUCTURE OF HEXAMERIC HIV-1 CA
  3H4E	X-RAY STRUCTURE OF HEXAMERIC HIV-1 CA
  3IG1	HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
  3JVW	HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323
  3JVY	HIV-1 PROTEASE MUTANT G86A WITH DARUNAVIR
  3JW2	HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR
  3MGE	X-RAY STRUCTURE OF HEXAMERIC HIV-1 CA
nucleocapsid
  1A1T	STRUCTURE OF THE HIV-1 NUCLEOCAPSID PROTEIN BOUND TO THE SL3 PSI-RNA RECOGNITION ELEMENT, NMR, 25 STRUCTURES
  1AAF	NUCLEOCAPSID ZINC FINGERS DETECTED IN RETROVIRUSES: EXAFS STUDIES ON INTACT VIRUSES AND THE SOLUTION-STATE STRUCTURE OF THE NUCLEOCAPSID PROTEIN FROM HIV-1
  1BJ6	1H NMR OF (12-53) NCP7/D(ACGCC) COMPLEX, 10 STRUCTURES
  1F6U	NMR STRUCTURE OF THE HIV-1 NUCLEOCAPSID PROTEIN BOUND TO STEM-LOOP SL2 OF THE PSI-RNA PACKAGING SIGNAL. IMPLICATIONS FOR GENOME RECOGNITION
  1HVN	ZINC-AND SEQUENCE-DEPENDENT BINDING TO NUCLEIC ACIDS BY THE N-TERMINAL ZINC FINGER DOMAIN OF THE HIV-1 NUCLEOCAPSID PROTEIN: NMR STRUCTURE OF THE COMPLEX WITH THE PSI-SITE ANALOG, D/ACGCC
  1HVO	ZINC-AND SEQUENCE-DEPENDENT BINDING TO NUCLEIC ACIDS BY THE N-TERMINAL ZINC FINGER DOMAIN OF THE HIV-1 NUCLEOCAPSID PROTEIN: NMR STRUCTURE OF THE COMPLEX WITH THE PSI-SITE ANALOG, D/ACGCC
  1MFS	DYNAMICAL BEHAVIOR OF THE HIV-1 NUCLEOCAPSID PROTEIN; NMR, 30 STRUCTURES
  1NC8	HIGH-RESOLUTION SOLUTION NMR STRUCTURE OF THE MINIMAL ACTIVE DOMAIN OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 NUCLEOCAPSID PROTEIN, 15 STRUCTURES
  1NCP	STRUCTURAL CHARACTERIZATION OF A 39 RESIDUE SYNTHETIC PEPTIDE CONTAINING THE TWO ZINC BINDING DOMAINS FROM THE HIV-1 P7 NUCLEOCAPSID PROTEIN BY CD AND NMR SPECTROSCOPY
  2EC7	SOLUTION STRUCTURE OF HUMAN IMMUNODIFICIENCY VIRUS TYPE-2 NUCLEOCAPSID PROTEIN
  2L4L	STRUCTURAL INSIGHTS INTO THE CTAR DNA RECOGNITION BY THE HIV-1 NUCLEOCAPSID PROTEIN: ROLE OF SUGAR DEOXYRIBOSES IN THE BINDING POLARITY OF NC
  3DOX	X-RAY STRUCTURE OF HIV-1 PROTEASE IN SITU PRODUCT COMPLEX
  3DPH	HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S)
  3IG1	HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
  3JVW	HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323
  3JVY	HIV-1 PROTEASE MUTANT G86A WITH DARUNAVIR
  3JW2	HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR
NEF
  1AVV	HIV-1 NEF PROTEIN, UNLIGANDED CORE DOMAIN
  1AVZ	V-1 NEF PROTEIN IN COMPLEX WITH WILD TYPE FYN SH3 DOMAIN
  1EFN	HIV-1 NEF PROTEIN IN COMPLEX WITH R96I MUTANT FYN SH3 DOMAIN
  1ZEC	NMR SOLUTION STRUCTURE OF NEF1-25, 20 STRUCTURES
  2NEF	HIV-1 NEF (REGULATORY FACTOR), NMR, 40 STRUCTURES
  2XI1	CRYSTAL STRUCTURE OF THE HIV-1 NEF SEQUENCED FROM A PATIENT'S SAMPLE
p51
  1HMV	THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
  1HNI	STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION
  1HNV	STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
  1QE1	CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
  1TV6	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707
  2B5J	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481
  2B6A	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50
  2BAN	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208
  2BE2	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239
  2I5J	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH, AN RNASE H INHIBITOR
  2IAJ	CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP
  2IC3	CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097
  2RKI	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
  2VG5	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
  2VG6	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
  2VG7	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
  2ZD1	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
  2ZE2	CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
  3BGR	CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
  3DI6	HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR
  3DLK	CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE, RT69A
  3DM2	CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
  3DMJ	CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
  3DOK	CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248.
  3DOX	X-RAY STRUCTURE OF HIV-1 PROTEASE IN SITU PRODUCT COMPLEX
  3DPH	HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S)
  3DRP	HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E
  3DRR	HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E
  3E01	HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2
  3HVT	STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
  3IG1	HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
  3IRX	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(3,7-DIMETHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-5-YL)-5- (5-METHYL-1,3,4-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3- METHYLBENZOTHIOATE.
  3IS9	CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 3,3'-(6-METHOXY-6-OXOHEX-1-ENE-1,1- DIYL)BIS(5-CYANO-6-METHOXYBENZOATE).
  3ISN	CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
  3ITH	CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
  3JSM	K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH TENOFOVIR-DIPHOSPHATE AS THE INCOMING NUCLEOTIDE SUBSTRATE
  3JVW	HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323
  3JVY	HIV-1 PROTEASE MUTANT G86A WITH DARUNAVIR
  3JW2	HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR
  3JYT	K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS- DNA AND COMPLEXED WITH DATP AS THE INCOMING NUCLEOTIDE SUBSTRATE
  3KJV	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
  3KK1	HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS- 9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
  3KK2	HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
  3KK3	HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
  3KLE	CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT, AZTPPPPA
  3KLF	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT, AZTPPPPA
  3KLG	CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
  3KLH	CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
  3KLI	CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE
  3LP0	HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
  3LP1	HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
  3LP2	HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
  3M8P	HIV-1 RT WITH NNRTI TMC-125
  3M8Q	HIV-1 RT WITH AMINOPYRIMIDINE NNRTI
  3NBP	HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2
  3QLH	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH MANICOL AT THE RNASE H ACTIVE SITE AND TMC278 (RILPIVIRINE) AT THE NNRTI BINDING POCKET
  3QO9	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
  3V4I	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
  3V6D	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
  3V81	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
RNAse
  1O1W	SOLUTION STRUCTURE OF THE RNASE H DOMAIN OF THE HIV-1 REVERSE TRANSCRIPTASE IN THE PRESENCE OF MAGNESIUM
  2JLE	NOVEL INDAZOLE NNRTIS CREATED USING MOLECULAR TEMPLATE HYBRIDIZATION BASED ON CRYSTALLOGRAPHIC OVERLAYS
  3HYF	CRYSTAL STRUCTURE OF HIV-1 RNASE H P15 WITH ENGINEERED E. COLI LOOP AND ACTIVE SITE INHIBITOR
p66
  1HMV	THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
  1HNI	STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION
  1HNV	STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
  1QE1	CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
  1TV6	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707
  2B5J	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481
  2B6A	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50
  2BAN	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208
  2BE2	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239
  2I5J	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH, AN RNASE H INHIBITOR
  2IAJ	CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP
  2IC3	CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097
  2RKI	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
  2VG5	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
  2VG6	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
  2VG7	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
  2YKM	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
  2YKN	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
  2ZD1	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
  2ZE2	CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
  3BGR	CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
  3DI6	HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR
  3DLK	CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE, RT69A
  3DM2	CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
  3DMJ	CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
  3DOK	CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248.
  3DOL	CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW695634.
  3DOX	X-RAY STRUCTURE OF HIV-1 PROTEASE IN SITU PRODUCT COMPLEX
  3DPH	HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S)
  3DRP	HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E
  3DRR	HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E
  3DRS	HIV REVERSE TRANSCRIPTASE K103N MUTANT IN COMPLEX WITH INHIBITOR R8D
  3E01	HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2
  3HVT	STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
  3IG1	HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
  3IRX	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(3,7-DIMETHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-5-YL)-5- (5-METHYL-1,3,4-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3- METHYLBENZOTHIOATE.
  3IS9	CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 3,3'-(6-METHOXY-6-OXOHEX-1-ENE-1,1- DIYL)BIS(5-CYANO-6-METHOXYBENZOATE).
  3ISN	CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
  3ITH	CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
  3JSM	K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH TENOFOVIR-DIPHOSPHATE AS THE INCOMING NUCLEOTIDE SUBSTRATE
  3JVW	HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323
  3JVY	HIV-1 PROTEASE MUTANT G86A WITH DARUNAVIR
  3JW2	HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR
  3JYT	K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS- DNA AND COMPLEXED WITH DATP AS THE INCOMING NUCLEOTIDE SUBSTRATE
  3K2P	HIV-1 REVERSE TRANSCRIPTASE ISOLATED RNASEH DOMAIN WITH THE INHIBITOR BETA-THUJAPLICINOL BOUND AT THE ACTIVE SITE
  3KJV	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
  3KK1	HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS- 9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
  3KK2	HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
  3KK3	HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
  3KLE	CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT, AZTPPPPA
  3KLF	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT, AZTPPPPA
  3KLG	CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
  3KLH	CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
  3KLI	CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE
  3LP0	HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
  3LP1	HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
  3LP2	HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
  3M8P	HIV-1 RT WITH NNRTI TMC-125
  3M8Q	HIV-1 RT WITH AMINOPYRIMIDINE NNRTI
  3NBP	HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2
  3QLH	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH MANICOL AT THE RNASE H ACTIVE SITE AND TMC278 (RILPIVIRINE) AT THE NNRTI BINDING POCKET
  3QO9	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
  3V4I	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
  3V6D	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
  3V81	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
integrase
  1B92	MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY
  1B9D	MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY
  1B9F	MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY
  1BHL	CACODYLATED CATALYTIC DOMAIN OF HIV-1 INTEGRASE
  1BI4	CATALYTIC DOMAIN OF HIV-1 INTEGRASE
  1BIS	HIV-1 INTEGRASE CORE DOMAIN
  1BIU	HIV-1 INTEGRASE CORE DOMAIN COMPLEXED WITH MG++
  1BIZ	HIV-1 INTEGRASE CORE DOMAIN
  1BL3	CATALYTIC DOMAIN OF HIV-1 INTEGRASE
  1E0E	N-TERMINAL ZINC-BINDING HHCC DOMAIN OF HIV-2 INTEGRASE
  1EX4	HIV-1 INTEGRASE CATALYTIC CORE AND C-TERMINAL DOMAIN
  1HYV	HIV INTEGRASE CORE DOMAIN COMPLEXED WITH TETRAPHENYL ARSONIUM
  1HYZ	HIV INTEGRASE CORE DOMAIN COMPLEXED WITH A DERIVATIVE OF TETRAPHENYL ARSONIUM.
  1IHV	SOLUTION STRUCTURE OF THE DNA BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, MINIMIZED AVERAGE STRUCTURE
  1IHW	SOLUTION STRUCTURE OF THE DNA BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 40 STRUCTURES
  1ITG	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HIV-1 INTEGRASE: SIMILARITY TO OTHER POLYNUCLEOTIDYL TRANSFERASES
  1K6Y	CRYSTAL STRUCTURE OF A TWO-DOMAIN FRAGMENT OF HIV-1 INTEGRASE
  1QMC	C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES
  1QS4	CORE DOMAIN OF HIV-1 INTEGRASE COMPLEXED WITH MG++ AND 1-(5- CHLOROINDOL-3-YL)-3-HYDROXY-3-(2H-TETRAZOL-5-YL)-PROPENONE
  1WJA	SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (D FORM), NMR, REGULARIZED MEAN STRUCTURE
  1WJB	SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (D FORM), NMR, 40 STRUCTURES
  1WJC	SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (E FORM), NMR, REGULARIZED MEAN STRUCTURE
  1WJD	SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (E FORM), NMR, 38 STRUCTURES
  1WJE	SOLUTION STRUCTURE OF H12C MUTANT OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE COMPLEXED TO CADMIUM, NMR, MINIMIZED AVERAGE STRUCTURE
  1WJF	SOLUTION STRUCTURE OF H12C MUTANT OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE COMPLEXED TO CADMIUM, NMR, 40 STRUCTURES
  2B4J	STRUCTURAL BASIS FOR THE RECOGNITION BETWEEN HIV-1 INTEGRASE AND LEDGF/P75
  2ITG	CATALYTIC DOMAIN OF HIV-1 INTEGRASE: ORDERED ACTIVE SITE IN THE F185H CONSTRUCT
  3AV9	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVA	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVB	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVC	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVF	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVG	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVH	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVI	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVJ	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVK	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVL	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVM	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3AVN	CRYSTAL STRUCTURES OF NOVEL ALLOSTERIC PEPTIDE INHIBITORS OF HIV INTEGRASE IN THE LEDGF BINDING SITE
  3DOX	X-RAY STRUCTURE OF HIV-1 PROTEASE IN SITU PRODUCT COMPLEX
  3DPH	HIV-1 CAPSID C-TERMINAL DOMAIN MUTANT (L211S)
  3F9K	TWO DOMAIN FRAGMENT OF HIV-2 INTEGRASE IN COMPLEX WITH LEDGF IBD
  3IG1	HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
  3JVW	HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323
  3JVY	HIV-1 PROTEASE MUTANT G86A WITH DARUNAVIR
  3JW2	HIV-1 PROTEASE MUTANT G86S WITH DARUNAVIR
  3LPT	HIV INTEGRASE
  3LPU	HIV INTEGRASE
  3NF6	STRUCTURAL BASIS FOR A NEW MECHANISM OF INHIBITION OF HIV INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DESIGN
  3NF7	STRUCTURAL BASIS FOR A NEW MECHANISM OF INHIBITION OF HIV INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DESIGN
  3NF8	STRUCTURAL BASIS FOR A NEW MECHANISM OF INHIBITION OF HIV INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DESIGN
  3NF9	STRUCTURAL BASIS FOR A NEW MECHANISM OF INHIBITION OF HIV INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DESIGN
  3NFA	STRUCTURAL BASIS FOR A NEW MECHANISM OF INHIBITION OF HIV INTEGRASE IDENTIFIED BY FRAGMENT SCREENING AND STRUCTURE BASED DESIGN
VIF
  3DCG	CRYSTAL STRUCTURE OF THE HIV VIF BC-BOX IN COMPLEX WITH HUMAN ELONGINB AND ELONGINC
VPR
  1DSJ	NMR SOLUTION STRUCTURE OF VPR50_75, 20 STRUCTURES
  1DSK	NMR SOLUTION STRUCTURE OF VPR59_86, 20 STRUCTURES
  1VPC	C-TERMINAL DOMAIN (52-96) OF THE HIV-1 REGULATORY PROTEIN VPR, NMR, 1 STRUCTURE
VPU
  1PI7	STRUCTURE OF THE CHANNEL-FORMING TRANS-MEMBRANE DOMAIN OF VIRUS PROTEIN "U" (VPU) FROM HIV-1
  1PI8	STRUCTURE OF THE CHANNEL-FORMING TRANS-MEMBRANE DOMAIN OF VIRUS PROTEIN "U" (VPU) FROM HIV-1
  1PJE	STRUCTURE OF THE CHANNEL-FORMING TRANS-MEMBRANE DOMAIN OF VIRUS PROTEIN "U"(VPU) FROM HIV-1
  1VPU	NMR SOLUTION STRUCTURE OF THE HIV-1 VPU CYTOPLASMIC DOMAIN, 9 STRUCTURES
  2GOF	THREE-DIMENSIONAL STRUCTURE OF THE TRANS-MEMBRANE DOMAIN OF VPU FROM HIV-1 IN ALIGNED PHOSPHOLIPID BICELLES
  2GOH	THREE-DIMENSIONAL STRUCTURE OF THE TRANS-MEMBRANE DOMAIN OF VPU FROM HIV-1 IN ALIGNED PHOSPHOLIPID BICELLES
  2JPX	A18H VPU TM STRUCTURE IN LIPID BILAYERS
  2K7Y	SOLUTION FOLD OF HIV-1 VIRUS PROTEIN U CYTOPLASMIC DOMAIN IN THE PRESENCE OF DPC MICELLES
VRC01
  3NGB	CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
Simian immunodeficiency virus
gp120
  2BF1	STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN
  3FUS	IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE
gp41
  1JPX	MUTATION THAT DESTABILIZE THE GP41 CORE: DETERMINANTS FOR STABILIZING THE SIV/CPMAC ENVELOPE GLYCOPROTEIN COMPLEX. WILD TYPE.
  1JQ0	MUTATION THAT DESTABILIZE THE GP41 CORE: DETERMINANTS FOR STABILIZING THE SIV/CPMAC ENVELOPE GLYCOPROTEIN COMPLEX. MUTANT STRUCTURE.
  1QBZ	THE CRYSTAL STRUCTURE OF THE SIV GP41 ECTODOMAIN AT 1.47 A
  1QCE	SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, RESTRAINED REGULARIZED MEAN STRUCTURE PLUS 29 SIMULATED ANNEALING STRUCTURES
  2EZO	SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, RESTRAINED REGULARIZED MEAN STRUCTURE
  2EZP	SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, MODELS 1-10 OF AN ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES
  2EZQ	SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, MODELS 11-20 OF AN ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES
  2EZR	SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, MODELS 21-30 OF AN ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES
  2EZS	SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, MODELS 31-40 OF AN ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES
  2SIV	SIV GP41 CORE STRUCTURE
matrix
p24
nucleocapsid
NEF
  3IK5	SIVMAC239 NEF IN COMPLEX WITH TCR ZETA ITAM 1 POLYPEPTIDE (A63-R80)
  3IOZ	SIVMAC239 NEF IN COMPLEX WITH A TCR ZETA POLYPEPTIDE DP1 (L51-D93)
p51
RNAse
p66
integrase
  1C6V	SIV INTEGRASE (CATALYTIC DOMAIN + DNA BIDING DOMAIN COMPRISING RESIDUES 50-293) MUTANT WITH PHE 185 REPLACED BY HIS (F185H)
VIF
VPR
VPU
VRC01